4 completed, 3 unknown. 7 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Completed 4, Unknown 3 |
| Phase 2 | 2 | Completed 2 |
Follow Infection, Bacterial: new trials by email Literature Review of Infection, Bacterial trials Research Report on Infection, Bacterial
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Absorption of Antibiotics With High Oral Bioavailability in Short-bowel Syndrome Amoxicillin, Levofloxacin, Ofloxacin - Short Bowel Syndrome, Infection, Bacterial | Phase 1 | Unknown | Central Hospital, Nancy, France | 10 | 2022-12-09 | 2024-08-29 |
| Safety, Tolerability, and Acceptability Study of Intravaginal Administration of LABTHERA-001 Capsules in Healthy Women Experimental: Low dose LABTHERA-001 capsule, Experimental: Medium dose LABTHERA-001 capsule, Experimental: High dose LABTHERA-001 capsule - Bacterial Vaginosis, Vaginal Disease | Phase 1 | Unknown | AtoGen Co. Ltd | 24 | 2022-11-02 | 2023-03-09 |
| A First-in-Human Study With XAB05 in Healthy Subjects Experimental - Infection, Bacterial | Phase 1 | Completed | Xenothera SAS | 25 | 2022-01-24 | 2022-08-12 |
| Addition of Probenecid to Penicillin-V Therapy Probenecid - Infection, Bacterial | Phase 1 / Phase 2 | Completed | Imperial College London | 21 | 2021-12-21 | 2025-01-30 |
| Penetration of the Innovative Antibiotic Gepotidacin Into Prostate and Tonsillar Tissue Gepotidacin - Gonorrhea, Infection, Bacterial | Phase 1 | Completed | Institut National de la Santé Et de la Recherche Médicale, France | 53 | 2021-01-29 | 2025-02-20 |
| Topical Silver Nanoparticles for Microbial Activity Silver nanoparticles, Topical approved anti-microbial gel - Foot Infection Fungal, Infection, Bacterial | Phase 1 | Unknown | Ahmed A. H. Abdellatif | 30 | 2019-11-13 | 2019-10-11 |
| Evaluation of ATx201 as a Topical Antibiotic Agent ATx201 dermal formulations 2% - Infection, Bacterial | Phase 1 / Phase 2 | Completed | UNION therapeutics | 73 | 2016-12-01 | 2018-03-20 |
Bacterial Infections (7) · Gonorrhea (1) · Short Bowel Syndrome (1) · Vaginal Diseases (1) · Vaginitis (1) · Vaginosis, Bacterial (1)
Bacterial Infections and Mycoses (7) · Infections (7) · Genital Diseases (2) · Urogenital Diseases (2) · Communicable Diseases (1) · Digestive System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Gastrointestinal Diseases (1) · Genital Diseases, Female (1) · Gram-Negative Bacterial Infections (1) · Intestinal Diseases (1) · Malabsorption Syndromes (1) · Neisseriaceae Infections (1) · Pathologic Processes (1)
Amoxicillin (1) · Control Groups (1) · Levofloxacin (1) · Ofloxacin (1) · Probenecid (1) · Trimethoprim, Sulfamethoxazole Drug Combination (1) · colloidal silver (1) · gepotidacin (1)
Ahmed A. H. Abdellatif (1) · AtoGen Co. Ltd (1) · Central Hospital, Nancy, France (1) · Imperial College London (1) · Institut National de la Santé Et de la Recherche Médicale, France (1) · UNION therapeutics (1) · Xenothera SAS (1)
Austria (2) · France (2) · Australia (1) · Netherlands (1) · Saudi Arabia (1) · United Kingdom (1)
Ahmed AH Abdellatif, PhD (1) · Christopher Argent, Dr. (1) · Khadid Abd-Elaziz, MD (1) · Markus Zeitlinger, MD (1) · Timothy Rawson, PhD (1)
PMID 15530127, PMID 1559306, PMID 20094812, PMID 2292168, PMID 24527370, PMID 24667978, PMID 29127863, PMID 6699766, PMID 7619677, PMID 7924123, PMID 9724482
2019 (1)